Nomura Holdings’s Fulgent Genetics FLGT Stock Holding History

Nomura Holdings’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-20,499	Closed	-$548K	–	1843
2023 Q3	$548K	Buy	+20,499	New	+$700K	﹤0.01%	1110

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nomura Holdings's FLGT Position: Q4 2023 in Review

Nomura Holdings sold out of Fulgent Genetics (FLGT) in Q4 2023, closing a stake of 20,499 shares — an estimated $548K sold.

Nomura Holdings first reported a position in FLGT in Q3 2023 and held it in 1 quarter. The position peaked at $548K in Q3 2023. 196 funds tracked by Wall St. Rank hold FLGT as of Q4 2023.

Nomura Holdings reported no remaining Fulgent Genetics position as of Q4 2023 after selling out during the quarter.
Nomura Holdings sold 20,499 Fulgent Genetics shares in Q4 2023, an estimated $548K.
Nomura Holdings first reported a position in Fulgent Genetics in Q3 2023 and held it in 1 quarter.
Nomura Holdings's Fulgent Genetics position peaked at $548K in Q3 2023.
196 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2023.

Based on Nomura Holdings's 13F filing for Q4 2023, filed 14 Feb 2024.